These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21780795)

  • 41. Targeting the purinome.
    Murray JM; Bussiere DE
    Methods Mol Biol; 2009; 575():47-92. PubMed ID: 19727611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PGVL Hub: An integrated desktop tool for medicinal chemists to streamline design and synthesis of chemical libraries and singleton compounds.
    Peng Z; Yang B; Mattaparti S; Shulok T; Thacher T; Kong J; Kostrowicki J; Hu Q; Na J; Zhou JZ; Klatte D; Chao B; Ito S; Clark J; Sciammetta N; Coner B; Waller C; Kuki A
    Methods Mol Biol; 2011; 685():295-320. PubMed ID: 20981530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 49. Illuminator: increasing synergies between medicinal and computational chemists.
    Gobbi A; Lardy M; Kim SH; Ruebsam F; Tran M; Webber SE; Xiang AX
    In Silico Biol; 2011-2012; 11(1-2):83-93. PubMed ID: 22475753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics.
    Lu H; Iuliano JN; Tonge PJ
    Curr Opin Chem Biol; 2018 Jun; 44():101-109. PubMed ID: 29986213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmaceutical structure montages as catalysts for design and discovery.
    Njarðarson JT
    Future Med Chem; 2012 May; 4(8):951-4. PubMed ID: 22650237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA-Encoded Dynamic Combinatorial Chemical Libraries.
    Reddavide FV; Lin W; Lehnert S; Zhang Y
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7924-8. PubMed ID: 26014116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring activity cliffs in medicinal chemistry.
    Stumpfe D; Bajorath J
    J Med Chem; 2012 Apr; 55(7):2932-42. PubMed ID: 22236250
    [No Abstract]   [Full Text] [Related]  

  • 56. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction.
    Siegel JB; Zanghellini A; Lovick HM; Kiss G; Lambert AR; St Clair JL; Gallaher JL; Hilvert D; Gelb MH; Stoddard BL; Houk KN; Michael FE; Baker D
    Science; 2010 Jul; 329(5989):309-13. PubMed ID: 20647463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combinatorial methods for small-molecule placement in computational enzyme design.
    Lassila JK; Privett HK; Allen BD; Mayo SL
    Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16710-5. PubMed ID: 17075051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The computational prediction of pharmaceutical crystal structures and polymorphism.
    Price SL
    Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.